New York, NYCIK 18849315 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
16 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Arbutus Biopharma Corp | 13.34M | $64.18M | 20.2% | 0 | Held |
| 2 | Roivant Sciences Ltd | 2.12M | $46.00M | 14.5% | −1.41M | Reduced |
| 3 | Ballys Corporation | 1.92M | $31.74M | 10.0% | +578.1K | Added |
| 4 | Omniab Inc |
| 14.22M |
| $26.31M |
| 8.3% |
| 0 |
| Held |
| 5 | Joyy Inc | 404.9K | $26.22M | 8.2% | 0 | Held |
| 6 | Gannett Co Inc | 4.77M | $24.59M | 7.7% | +1.19M | Added |
| 7 | Genworth Finl Inc | 2.54M | $22.94M | 7.2% | −1.16M | Reduced |
| 8 | Cadiz Inc | 3.99M | $22.37M | 7.0% | 0 | Held |
| 9 | Sable Offshore Corp | 1.91M | $17.24M | 5.4% | +1.91M | New |
| 10 | Uniqure NV | 459.0K | $10.98M | 3.5% | +459.0K | New |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio